Browse Tag

IPO

Meesho Limited Share Price Today (23 December 2025): MEESHO Stock Extends Sell-Off After Post-IPO Surge—Latest News, Analyst Targets, and Outlook

Meesho Limited Share Price Today (23 December 2025): MEESHO Stock Extends Sell-Off After Post-IPO Surge—Latest News, Analyst Targets, and Outlook

Meesho Limited (NSE: MEESHO | BSE: 544632) is having the kind of post-IPO week that makes both momentum traders and long-term investors sit up straight: a blistering rally, followed by a sharp, liquid-looking reversal. On December 23, 2025, Meesho shares
7-Eleven CEO Joe DePinto to Retire; Stan Reynolds and Doug Rosencrans Named Interim Co-CEOs as Seven & i Pushes U.S. Turnaround and 2026 IPO Plan

7-Eleven CEO Joe DePinto to Retire; Stan Reynolds and Doug Rosencrans Named Interim Co-CEOs as Seven & i Pushes U.S. Turnaround and 2026 IPO Plan

DALLAS / TOKYO — December 22, 2025 — 7‑Eleven’s North American business is heading into a major leadership transition just as its Japanese parent, Seven & i Holdings, accelerates a broader turnaround and prepares the groundwork for a future U.S.
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease
Meesho Limited Stock (NSE: MEESHO) Today: Post-IPO Surge, UBS Target Price, Short-Squeeze Signals, and the 2026 Outlook (Dec 21, 2025)

Meesho Limited Stock (NSE: MEESHO) Today: Post-IPO Surge, UBS Target Price, Short-Squeeze Signals, and the 2026 Outlook (Dec 21, 2025)

December 21, 2025 — Meesho Limited’s stock has become the headline-grabber of India’s late-2025 IPO wave, delivering a blistering post-listing run that’s sparked equal parts excitement and unease on Dalal Street. After debuting on December 10, 2025, Meesho’s shares surged
Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements,
20 December 2025
Saudi Stock Exchange (Tadawul) Update on 20 Dec 2025: TASI Rebounds From Two‑Year Low as Oil, Rate Cuts and IPO Sentiment Shape 2026

Saudi Stock Exchange (Tadawul) Update on 20 Dec 2025: TASI Rebounds From Two‑Year Low as Oil, Rate Cuts and IPO Sentiment Shape 2026

As Saudi Arabia heads into the final stretch of 2025, the Saudi Stock Exchange (Tadawul) is finishing the year in a tense, valuation-sensitive mood—caught between supportive domestic monetary conditions and stubborn external headwinds led by oil-market weakness. Because Saturday, 20
20 December 2025
1 2 3 14
Go toTop